Literature DB >> 18180379

Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor.

Lisette M Acevedo1, Samuel Barillas, Sara M Weis, Joachim R Göthert, David A Cheresh.   

Abstract

Semaphorin 3A (Sema3A), a known inhibitor of axonal sprouting, also alters vascular patterning. Here we show that Sema3A selectively interferes with VEGF- but not bFGF-induced angiogenesis in vivo. Consistent with this, Sema3A disrupted VEGF- but not bFGF-mediated endothelial cell signaling to FAK and Src, key mediators of integrin and growth factor signaling; however, signaling to ERK by either growth factor was unperturbed. Since VEGF is also a vascular permeability (VP) factor, we examined the role of Sema3A on VEGF-mediated VP in mice. Surprisingly, Sema3A not only stimulated VEGF-mediated VP but also potently induced VP in the absence of VEGF. Sema3A-mediated VP was inhibited either in adult mice expressing a conditional deletion of endothelial neuropilin-1 (Nrp-1) or in wild-type mice systemically treated with a function-blocking Nrp-1 antibody. While both Sema3A- and VEGF-induced VP was Nrp-1 dependent, they use distinct downstream effectors since VEGF- but not Sema3A-induced VP required Src kinase signaling. These findings define a novel role for Sema3A both as a selective inhibitor of VEGF-mediated angiogenesis and a potent inducer of VP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180379      PMCID: PMC2254547          DOI: 10.1182/blood-2007-08-110205

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  Distinct roles for secreted semaphorin signaling in spinal motor axon guidance.

Authors:  Andrea B Huber; Artur Kania; Tracy S Tran; Chenghua Gu; Natalia De Marco Garcia; Ivo Lieberam; Dontais Johnson; Thomas M Jessell; David D Ginty; Alex L Kolodkin
Journal:  Neuron       Date:  2005-12-22       Impact factor: 17.173

2.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

Authors:  D R Senger; S J Galli; A M Dvorak; C A Perruzzi; V S Harvey; H F Dvorak
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

3.  Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development.

Authors:  Chenghua Gu; E Rene Rodriguez; Dorothy V Reimert; Tianzhi Shu; Bernd Fritzsch; Linda J Richards; Alex L Kolodkin; David D Ginty
Journal:  Dev Cell       Date:  2003-07       Impact factor: 12.270

4.  Semaphorin-plexin signaling guides patterning of the developing vasculature.

Authors:  Jesús Torres-Vázquez; Aaron D Gitler; Sherri D Fraser; Jason D Berk; Mark C Fishman; Sarah Childs; Jonathan A Epstein; Brant M Weinstein
Journal:  Dev Cell       Date:  2004-07       Impact factor: 12.270

5.  Semaphorin-3F is an inhibitor of tumor angiogenesis.

Authors:  Ofra Kessler; Niva Shraga-Heled; Tali Lange; Noga Gutmann-Raviv; Edmond Sabo; Limor Baruch; Marcelle Machluf; Gera Neufeld
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

6.  Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium.

Authors:  Joachim R Göthert; Sonja E Gustin; J Anke M van Eekelen; Uli Schmidt; Mark A Hall; Stephen M Jane; Anthony R Green; Berthold Göttgens; David J Izon; C Glenn Begley
Journal:  Blood       Date:  2004-06-08       Impact factor: 22.113

7.  Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction.

Authors:  Sara Weis; Satoshi Shintani; Alberto Weber; Rudolf Kirchmair; Malcolm Wood; Adrianna Cravens; Heather McSharry; Atsushi Iwakura; Young-Sup Yoon; Nathan Himes; Deborah Burstein; John Doukas; Richard Soll; Douglas Losordo; David Cheresh
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

8.  Definition of two angiogenic pathways by distinct alpha v integrins.

Authors:  M Friedlander; P C Brooks; R W Shaffer; C M Kincaid; J A Varner; D A Cheresh
Journal:  Science       Date:  1995-12-01       Impact factor: 47.728

9.  Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis.

Authors:  Sara Weis; Jianhua Cui; Leo Barnes; David Cheresh
Journal:  J Cell Biol       Date:  2004-10-25       Impact factor: 10.539

10.  Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis.

Authors:  John D Hood; Ricardo Frausto; William B Kiosses; Martin A Schwartz; David A Cheresh
Journal:  J Cell Biol       Date:  2003-09-01       Impact factor: 10.539

View more
  92 in total

Review 1.  Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer.

Authors:  Atsuko Sakurai; Colleen L Doçi; Colleen Doci; J Silvio Gutkind
Journal:  Cell Res       Date:  2011-12-13       Impact factor: 25.617

Review 2.  Semaphorins in angiogenesis and tumor progression.

Authors:  Gera Neufeld; Adi D Sabag; Noa Rabinovicz; Ofra Kessler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 3.  Regulation of immune cell responses by semaphorins and their receptors.

Authors:  Hyota Takamatsu; Tatsusada Okuno; Atsushi Kumanogoh
Journal:  Cell Mol Immunol       Date:  2010-02-01       Impact factor: 11.530

4.  PlexinD1 is required for proper patterning of the periocular vascular network and for the establishment of corneal avascularity during avian ocular development.

Authors:  Sam C Kwiatkowski; Ana F Ojeda; Peter Y Lwigale
Journal:  Dev Biol       Date:  2016-01-16       Impact factor: 3.582

5.  Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma.

Authors:  Sabag D Adi; Nasren Eiza; Jacob Bejar; Hila Shefer; Shira Toledano; Ofra Kessler; Gera Neufeld; Elias Toubi; Zahava Vadasz
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

6.  Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches.

Authors:  Erich R Mackow; Elena E Gorbunova; Nadine A Dalrymple; Irina N Gavrilovskaya
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

7.  Inflammation and Lymphedema Are Exacerbated and Prolonged by Neuropilin 2 Deficiency.

Authors:  Patrick Mucka; Nicholas Levonyak; Elena Geretti; Bernadette M M Zwaans; Xiaoran Li; Irit Adini; Michael Klagsbrun; Rosalyn M Adam; Diane R Bielenberg
Journal:  Am J Pathol       Date:  2016-10-14       Impact factor: 4.307

8.  Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells.

Authors:  Boaz Kigel; Asya Varshavsky; Ofra Kessler; Gera Neufeld
Journal:  PLoS One       Date:  2008-09-26       Impact factor: 3.240

Review 9.  Endothelial fatty acid transport: role of vascular endothelial growth factor B.

Authors:  Carolina Hagberg; Annika Mehlem; Annelie Falkevall; Lars Muhl; Ulf Eriksson
Journal:  Physiology (Bethesda)       Date:  2013-03

10.  Tissue-penetrating delivery of compounds and nanoparticles into tumors.

Authors:  Kazuki N Sugahara; Tambet Teesalu; Priya Prakash Karmali; Venkata Ramana Kotamraju; Lilach Agemy; Olivier M Girard; Douglas Hanahan; Robert F Mattrey; Erkki Ruoslahti
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.